Ed note: The slides below from Kaiser’s Senior Causus give an updated review. Two points you might not be aware of: Washington State hospitals are inundated with COVID patients often operating above 100% capacity; and at least 3 promising medications being studied with results likely in late fall/early winter–Molnupiravir (Merck and Ridgeback Biotherapeutics) being tested in Seattle, PF-07321332 (Pfizer), and AT-527 (Roche and Atea Pharmaceuticals)
Loading…
Reload document 
Open in new tab